title: Durability of aneurysm treatments in patients with active Behcet's disease.
abstract: OBJECTIVE
  Aneurysms in Behcet's disease are rare, serious, and recurrent. To achieve durable treatment, patients should receive immunosuppressive therapy before intervention to induce remission. We present early and long-term results of emergency cases of active Behcet's disease, which did not permit waiting for suppressive treatment.
  
  
  METHODS
  The study was undertaken on all cases admitted to the vascular unit, King Fahd Hospital of University for aneurysm treatment in patients with active Behcet's disease over about 10 years. All patients had exclusion of the aneurysm either by open surgery or endovascular intervention. Morbidities and mortality were recorded within the hospital admission and on the follow-up.
  
  
  RESULTS
  During the study period, three cases were included. All interventions were successful and lifesaving. However, two cases, treated with surgical interposition grafts, were blocked in the intermediate term follow-up (2-12 months) and one case, treated with endovascular treatment, complicated with pseudoaneurysm at femoral puncture site after six months.
  
  
  CONCLUSIONS
  Although early results were good, intermediate ones were not satisfactory because of progressive graft thrombosis and formation of new aneurysms. Awareness of these rare cases help for early identification and proper immunosuppressive before emergency vascular intervention is warranted.
authors.affiliation: Department of General Surgery (Vascular division), University of Dammam, Al-Khobar, Saudi Arabia elsharawya@yahoo.co.uk.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Elsharawy
authors.affiliation: Department of General Surgery (Vascular division), University of Dammam, Al-Khobar, Saudi Arabia.
authors.forename: Aymen
authors.initials: A
authors.lastname: Elsaid
authors.affiliation: Department of Radiology, University of Dammam, Al-Khobar, Saudi Arabia.
authors.forename: Bander
authors.initials: B
authors.lastname: Al-Dhafery
authors.affiliation: Department of Radiology, University of Dammam, Al-Khobar, Saudi Arabia.
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Alghnimi
authors.affiliation: Department of General Surgery (Vascular division), University of Dammam, Al-Khobar, Saudi Arabia.
authors.forename: Fatimah
authors.initials: F
authors.lastname: Almabyouq
mesh_terms: D000328:Adult; D000783:Aneurysm / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery*; D017541:Aneurysm, False / Q000209:etiology; D015901:Angiography, Digital Subtraction; D001528:Behcet Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D001807:Blood Vessel Prosthesis; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000295:instrumentation; D000072226:Computed Tomography Angiography; D057510:Endovascular Procedures / Q000009:adverse effects / Q000295:instrumentation; D006083:Graft Occlusion, Vascular / Q000209:etiology; D006785:Hospitals, University; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D012008:Recurrence; D012307:Risk Factors; D012529:Saudi Arabia; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D011138:Polytetrafluoroethylene
keywords: Behcet’s disease; arterial aneurysm; endovascular treatment; polytetrafluroethylene (PTFE) graft